For the year ending 2025-12-31, IDXG made $38,728K in revenue. $24,575K in net income. Net profit margin of 63.46%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue, net | 38,728 | 46,926 | ||
| Cost of revenue | 14,598 | 17,001 | ||
| Gross profit | 24,130 | 29,925 | ||
| Sales and marketing | 9,924 | 11,655 | ||
| Research and development | 642 | 676 | ||
| General and administrative | 9,480 | 9,486 | ||
| Total operating expenses | 20,046 | 21,817 | ||
| Operating income from continuing operations | 4,084 | 8,108 | ||
| Other expense, net | - | 499 | ||
| Note payable interest expense | 168 | 625 | ||
| Interest accretion expense | - | 34 | ||
| Other expense, net | -142 | - | ||
| Income from continuing operations before tax | 3,774 | 6,950 | ||
| (benefit) provision for income taxes | -21,210 | 4 | ||
| Income from continuing operations | 24,984 | 6,946 | ||
| Loss from discontinued operations, net of tax | -409 | -244 | ||
| Net income | 24,575 | 6,702 | ||
| Less adjustment for preferred stock deemed dividend | - | 464 | ||
| Net income attributable to common stockholders | 24,575 | 6,238 | ||
| Basic EPS | 5.55 | 1.42 | ||
| Diluted EPS | 0.89 | 0.4 | ||
| Basic Average Shares | 4,424,000 | 4,387,000 | ||
| Diluted Average Shares | 27,695,000 | 15,734,000 | ||
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)